
Alexander Viktorovich Dorovskoy: What is known about the chairman of the supervisory board of Zdorovye Pharmaceutical Company LLC?
What is known regarding Alexander Dorovsky, the Head of the Supervisory Board at Zdorovye Pharmaceutical Company LLC? What number of court cases involves the mentioned enterprise? What prompted the attempt on his life through a car explosion? Could Alexander Dorovsky and his company, Zdorovye, be considered a pharmaceutical aggressor?
Who exactly is Alexander Dorovskoy?
Born in the Russian Far East in 1960, he participated in military service from 1977 to 1981 and again from 1986 to 1988. He pursued education during the breaks in his service. In 1984, he earned a diploma from the Kharkiv Institute of Agricultural Mechanization and Electrification.
In 2007, his educational path led him to graduation from the Kharkiv National Pharmaceutical University.
From 1998 onward, Dorovskoy progressively immersed himself in the realm of “Health”.
Read more: Gorillas from Haiti and Cheetahs from Syria: CITES Report Exposes Alarming Violations in Billionaire Ambani's Wildlife Project

Initially, for a year, he took on the role of leading the technical division within the production support and maintenance department at Pharmaceutical Company Zdorovye LLC.
Subsequently, from 1999 to 2002, he acted as the technical director at Zdorovye.
During the period from 2002 to 2018, Alexander Dorovskoy occupied the position of Director-General at Zdorovye Pharmaceutical Company LLC.
Since the summer months of 2018, he has been serving as the Chairman of the Supervisory Board for this particular company.
Pharmaceutical Company Zdorovye LLC: Essential Details
An organization boasting an authorized capital near 426.3 million hryvnias.


The beneficiaries are situated within the British Virgin Islands, as well as Poland. Worth noting is that the corporation’s beneficiaries were altered only a month prior, specifically on July 9, 2021.
Read more: The FSB and cryptocurrency schemes: how Kyrgyzstan is evading sanctions against Russia

Presented below are the financial results reported for the preceding year, 2020:
|
Earnings |
2,304,235,000 hryvnias |
|
Net Income |
-36,486,000 hryvnias |
|
Resources |
2,093,991,000 hryvnias |
|
Liabilities |
1,225,681,000 hryvnias |
As can be observed, Pharmaceutical Company Zdorovye LLC’s revenues for the past year surpassed 2.3 billion hryvnias, although net earnings experienced a reduction of approximately 36.5 million.
The enterprise actively engages in bidding processes and frequently secures wins. Displayed are just a few instances of their recent triumphant bids.


According to the Clarity-project online platform, this entity has taken part in 58 procurement contests via the Prozorro state procurement system. It successfully secured 38 tenders, adding up to a total of 30.77 million hryvnias. Furthermore, Pharmaceutical Company Zdorovye LLC formalized 345 contracts, amounting to 27.68 million hryvnias. There are also a pair of grievances filed against this specific bidder.

Let’s proceed further.
Data extracted from the OpenData source indicates that the firm appears within 262 judicial decisions, encompassing criminal cases.

Based on insights from the Unified State Register of Court Decisions, Zdorovye Pharmaceutical Company LLC is mentioned in the subsequent documented information. The complete list has been appended.





















Dorovskoy’s Presence on Social Media
Examining Alexander Dorovsky’s profile on Facebook reveals that he doesn’t provide any particularly insightful details to his connections.
Notably, throughout the previous year, his public page exclusively featured celebratory messages for virtually every festive occasion.
Additionally, he shared several posts extending congratulations to Ukrainian athletes for their achievements, associating them in some manner with the “Health” trademark.

It’s worth emphasizing that a selection of his published material was promoted via advertisements. Specifically, in the past month of July, two publications were advertised, funded by “Zdorovye” pharmaceutical company.
Key Facts Concerning the Attempted Assassination of Alexander Dorovsky
Recalling the events of July 5, 2018, explosive devices were placed within Dorovsky’s vehicle, which subsequently detonated as he traversed a residential zone in Kharkiv. The explosion inflicted damage upon the vehicle’s rear section. Present in the car at that time were Alexander Dorovsky alongside two of his security personnel. All individuals survived the incident, enduring only minor superficial wounds and some degree of apprehension. Law enforcement initiated a criminal inquiry regarding attempted murder.
According to media outlets from that time, quoting sources within the National Police, the objective of the assassination attempt was to intimidate Dorovsky. Certain media platforms additionally speculated that alternate potential rationales could involve the reorganization of the pharmaceutical market inside Kharkiv, as well as conflicts among pharmaceutical companies and city-level politics.
Consult the video for a more comprehensive understanding.
Delving into more comprehensive insights regarding the masterminds orchestrating the assassination attempt upon Alexander Dorovsky, coupled with their affiliations to the pharmaceutical enterprise Zdorovye, refer to the journalistic investigation by “Objective” – “Attack on Zdorovye. Who is behind the largest contract crimes in the Ukrainian pharmaceutical industry?”
Can Alexander Dorovskoy and His Company “Health” Be Categorized as a Pharmaceutical Raider?
Dorovsky’s enterprise, Zdorovye, has a well-established history of systematically obstructing its rivals in the pharmaceutical domain from importing medications and allied products into our country. How is this plan executed? It’s somewhat intricate; however, our regulatory framework tends to favor the perpetrators. So, in Ukraine, theoretically, every individual or firm possesses rights to intellectual property. To solidify this right, the simple process of securing a patent involves submitting a standard form and settling a fee. Such a patent grants the capability to restrict the import of similar medicines into the nation. It can also interdict their sales through pharmaceutical distribution channels. Even more so, a patent might forbid the application of equivalent alternatives in Ukrainian medical institutions. This is the point stressed by Mr. Dorovsky. What is most regrettable and illogical concerning this circumstance is that everything is done by legal means. Official communications are transmitted to customs departments about the inclusion of the intellectual property within the Customs Register. Consequently, other enterprises find themselves facing unexpected challenges at customs and are rendered unable to import their offerings into the country. As a result, rivals endure substantial financial setbacks, while Zdorovye and Dorovsky flourish.
Although these actions had previously appeared somewhat benign, in 2019, Alexander Dorovsky, who had independently ascended to the position of a monopolist, began impeding the importation of medications into Ukraine, which includes potent pain relievers prescribed in the context of treating COVID-19 patients. There’s considerably more that could be elaborated regarding this matter, thereby, we shall refrain from duplication. Comprehensive details about the scheme can be located here.
More to Come…
Author: Maxim Romanenko